The marketing push for hypertension-treating renal denervation technology, clinical darling turned black sheep, has some doctors raising eyebrows at the EuroPCR conference in Paris this week.
Attendees at this year's EuroPCR conference in Paris cast a wary eye on medical device makers' efforts to promote renal denervation in treatment of hypertension, taking to Twitter to note and sometimes chide companies for putting "marketing before science."
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nfCT2N
Cap comentari:
Publica un comentari a l'entrada